Galapagos | Markedsværdi



Market Capitalization Lave om Dato
argenx SE EUR 36.22B 7.18B 2024-12
AstraZeneca GBP 162.31B 17.34B 2024-12
Biogen USD 22.28B 5.95B 2024-12
Genmab DKK 98.78B 8.42B 2024-12
Gilead Sciences USD 115.12B 10.74B 2024-12
GlaxoSmithKline GBP 55.81B 7.05B 2024-12
GRIFOLS EUR 5.75B 728.47M 2024-12
Hikma Pharmaceutical GBP 4.2B 240.73M 2024-06
Incyte USD 13.31B 576M 2024-12
Merck EUR 68.69B 1.41B 2024-09
Neurocrine Biosciences USD 13.82B 2.18B 2024-12
Novartis CHF 194.25B 18.5B 2024-12
Sanofi EUR 118.41B 10.58B 2024-12
Vertex Pharmaceuticals USD 103.71B 16.33B 2024-12



Galapagos Markedsværdi - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.